US Patent Issued to Arizona Board of Regents on Behalf of Arizona State University on Nov. 11 for "Plant-produced mABs against chikungunya virus with enhanced effector function and efficacy" (Arizona Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,862, issued on Nov. 11, was assigned to Arizona Board of Regents on Behalf of Arizona State University (Tempe, Ariz.).

"Plant-produced mABs against chikungunya virus with enhanced effector function and efficacy" was invented by Qiang Chen (Chandler, Ariz.), Jonathan Hurtado (Chandler, Ariz.), Haiyan Sun (Chandler, Ariz.) and Huafang Lai (Chandler, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are monoclonal antibodies against Chikungunya virus having enhanced effector function and efficacy, methods of producing them, and methods of treatment of Chikungunya viral infection using the antibodies."

The patent was filed on June 4, 2020,...